Preaddiction—A Missing Concept for Treating Substance Use Disorders

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020

Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis

Glechner, A., Keuchel, L., Affengruber, L., Titscher, V., Sommer, I., Matyas, N., Wagner, G., Kien, C., Klerings, I., & Gartlehner, G. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.003 · Cited by 226

Randomized Clinical Trial of Computerized and Clinician-Delivered CBT in Comparison With Standard Outpatient Treatment for Substance Use Disorders: Primary Within-Treatment and Follow-Up Outcomes

Kiluk, B. D., Nich, C., Buck, M. B., Devore, K. A., Frankforter, T. L., LaPaglia, D. M., Muvvala, S. B., & Carroll, K. M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17090978 · Cited by 138

Neurofunctional domains derived from deep behavioral phenotyping in alcohol use disorder

Kwako, L. E., Schwandt, M. L., Ramchandani, V. A., Diazgranados, N., Koob, G. F., Volkow, N. D., Blanco, C., & Goldman, D. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18030357 · Cited by 138

Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids

Marel, C., Sunderland, M., Mills, K. L., Slade, T., Teesson, M., & Chapman, C. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.10.010 · Cited by 114

Pathophysiology of Addiction

Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch22 · Cited by 14

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503

Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults

Mennis, J. L., McKeon, T. P., & Stahler, G. J. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107552 · Cited by 131

Alcohol Use Disorder Treatment: Problems and Solutions

Koob, G. F. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031323-115847 · Cited by 126

Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Haney, M., Vallée, M., Fabre, S., Collins, S. L., Zanese, M., Campistron, G., Arout, C. A., Foltin, R. W., Cooper, Z. D., Kearney-Ramos, T. E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02381-w · Cited by 84

Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes

Toikumo, S., Jennings, M. V., Pham, B. K., Lee, H., Mallard, T. T., Bianchi, S. B., Meredith, J. J., Vilar‐Ribó, L., Xu, H., Hatoum, A. S., et al. (2024) · Nature Human Behaviour · doi:10.1038/s41562-024-01851-6 · Cited by 62

Addictive and other mental disorders: a call for a standardized definition of dual disorders

Szerman, N., Torrens, M., Maldonado, R. J., Balhara, Y. P. S., Salom, C., Maremmani, I., Sher, L., Didia-Attas, J., Chen, J., & Baler, R. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02212-5 · Cited by 59

Opioid use disorder: current trends and potential treatments

Lee, Y. K., Gold, M. S., Blum, K., Thanos, P. K., Hanna, C., & Fuehrlein, B. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1274719 · Cited by 59

The Genetically Informed Neurobiology of Addiction (GINA) model

Bogdan, R., Hatoum, A. S., Johnson, E. C., & Arpana Agrawal, A. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00656-8 · Cited by 56

The centrality of craving in network analysis of five substance use disorders

Gauld, C., Baillet, E., Micoulaud‐Franchi, J., Kervran, C., Serre, F., & Auriacombe, M. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109828 · Cited by 54

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

Blum, K., Han, D. C., Gupta, A., Baron, D. A., Braverman, E. R., Dennen, C. A., Kazmi, S., Llanos-Gomez, L., Badgaiyan, R. D., Elman, I., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091385 · Cited by 31

The collaborative study on the genetics of alcoholism: Sample and clinical data

Dick, D. M., Balcke, E., McCutcheon, V. V., Francis, M. W., Kuo, S. I., Salvatore, J. E., Meyers, J. L., Bierut, L. J., Schuckit, M. A., HESSELBROCK, V. M., et al. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12860 · Cited by 31

Association between vmPFC gray matter volume and smoking initiation in adolescents

Xiang, S., Jia, T., Xie, C., Cheng, W., Chaarani, B., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Desrivières, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40079-2 · Cited by 33

New approaches to deep phenotyping in addictions.

Watts, A. L., Latzman, R. D., Boness, C. L., Kotov, R., Keyser‐Marcus, L., DeYoung, C. G., Krueger, R. F., Zald, D. H., Moeller, F. G., & Ramey, T. (2022) · Psychology of Addictive Behaviors · doi:10.1037/adb0000878 · Cited by 31

Brain Networks and Adolescent Alcohol Use

Yip, S. W., Lichenstein, S. D., Liang, Q., Chaarani, B., Dager, A. D., Pearlson, G. D., Banaschewski, T., Bokde, A. L. W., Desrivières, S., Flor, H., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2949 · Cited by 28

Neuroimaging biomarkers of addiction

Ekhtiari, H., Sangchooli, A., Carmichael, O. T., Moeller, F. G., O’Donnell, P., Oquendo, M. A., Paulus, M. P., Pizzagalli, D. A., Ramey, T., Schacht, J. P., et al. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00334-x · Cited by 29

Diagnostic Criteria for Identifying Individuals at High Risk of Progression From Mild or Moderate to Severe Alcohol Use Disorder

Miller, A. P., Kuo, S. I., Johnson, E. C., Tillman, R., Brislin, S. J., Dick, D. M., Kamarajan, C., Kinreich, S., Kramer, J., McCutcheon, V. V., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37192 · Cited by 29

Cannabis Legalization and the Decline of Cannabis Use Disorder (CUD) Treatment Utilization in the US

Mennis, J. L., Stahler, G. J., & Mason, M. J. (2023) · Current Addiction Reports · doi:10.1007/s40429-022-00461-4 · Cited by 27

A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder

Celik, M., Gold, M. S., & Fuehrlein, B. (2024) · Brain Sciences · doi:10.3390/brainsci14030294 · Cited by 25

Initiation of and Escalation to High-Intensity Drinking in Young Adults

Patrick, M. E., Evans‐Polce, R. J., Arterberry, B. J., & Terry‐McElrath, Y. M. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2022.5642 · Cited by 25

Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder

Aloi, M., Liuzza, M. T., Rania, M., Carbone, E. A., de Filippis, R., Gearhardt, A. N., & Segura‐Garcìa, C. (2024) · Journal of Behavioral Addictions · doi:10.1556/2006.2023.00074 · Cited by 22

Trends in Opioid Misuse Among Individuals Aged 12 to 21 Years in the US

Warren, L. K., Adams, J. W., & Bobashev, G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.16276 · Cited by 21

Trends in Substance-Related Visits Among Youth to US Children’s Hospitals, 2016–2021: An Analysis of the Pediatric Health Information System Database

Ball, A., Hadland, S. E., Rodean, J., Hall, M., Mendoza, J. A., & Ahrens, K. R. (2024) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2024.02.016 · Cited by 20

Reevaluating the brain disease model of addiction

Blithikioti, C., Fried, E. I., Albanese, E., Field, M., & Cristea, I. A. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00060-4 · Cited by 19

Extended access to fentanyl vapor self-administration leads to addiction-like behaviors in mice: Blood chemokine/cytokine levels as potential biomarkers

Marchette, R. C. N., Carlson, E. R., Said, N., Koob, G. F., & Vendruscolo, L. F. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100057 · Cited by 18

Why haven't we solved the addiction crisis?

Blum, K., Bowirrat, A., Llanos-Gomez, L., Downs, B. W., Bagchi, D., Barh, D., Modestino, E. J., Baron, D. A., McLaughlin, T., Thanos, P. K., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120404 · Cited by 21

Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index

Blum, K., Han, D. C., Bowirrat, A., Downs, B. W., Bagchi, D., Thanos, P. K., Baron, D. A., Braverman, E. R., Dennen, C. A., Gupta, A., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111772 · Cited by 19

Estimated Prevalence of Substance Use Disorders Among US Adolescents and Emerging Adults by Substance Class, Severity, and Age, 2022

Adams, Z. W., Dellucci, T. V., Agley, J. D., Bixler, K., Sullivan, M., Hinckley, J. D., & Hulvershorn, L. A. (2025) · JAACAP Open · doi:10.1016/j.jaacop.2025.01.002 · Cited by 16

Stigmata that are desired: contradictions in addiction

Vanyukov, M. M. (2023) · Addiction Research & Theory · doi:10.1080/16066359.2023.2238603 · Cited by 16

Theory-driven computational models of drug addiction in humans: Fruitful or futile?

Lim, T. V., & Ersche, K. D. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100066 · Cited by 16

Does polygenic risk for substance‐related traits predict ages of onset and progression of symptoms?

Kranzler, H. R., Feinn, R., Xu, H., Ho, B. L., Saini, D., Nicastro, O. R., Jacoby, A., Toikumo, S., Gelernter, J. E., Hartwell, E. E., et al. (2023) · Addiction · doi:10.1111/add.16210 · Cited by 14

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family

Dennen, C. A., Blum, K., Bowirrat, A., Thanos, P. K., Elman, I., Ceccanti, M., Badgaiyan, R. D., McLaughlin, T., Gupta, A., Bajaj, A., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111864 · Cited by 13

The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial

Serre, F., Moriceau, S., Donnadieu, L., Forcier, C., Garnier, H., Alexandre, J., Dupuy, L., Philip, P., Levavasseur, Y., de Sevin, É., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1143167 · Cited by 14

How to Combat the Global Opioid Crisis.

Catherine Dennen, A., Blum, K., Eric Braverman, R., Bowirrat, A., Gold, M. S., Elman, I., Panayotis Thanos, K., Baron, D. A., Gupta, A., Edwards, D., et al. (2023) · PubMed · Cited by 11

Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography

(2024) · Journal of Addiction Psychiatry · doi:10.17756/jap.2024-043 · Cited by 11

Social media interventions addressing physical activity among emerging adults who use cannabis: A pilot trial of feasibility and acceptability

Bonar, E. E., Chapman, L., Pagoto, S., Tan, C. Y., Duval, E. R., McAfee, J., Collins, R. L., & Walton, M. A. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109693 · Cited by 10

Sex Differences in Cocaine Sensitization Vary by Mouse Strain

Chapp, A. D., Nwakama, C. A., Thomas, M. J., Meisel, R. L., & Mermelstein, P. G. (2023) · Neuroendocrinology · doi:10.1159/000530591 · Cited by 10

Digital biomarker applications across the spectrum of opioid use disorder

Rigatti, M., Chapman, B. P., Chai, P. R., Smelson, D. A., Babu, K. M., & Carreiro, S. (2023) · Cogent Mental Health · doi:10.1080/28324765.2023.2240375 · Cited by 9

The genetic architecture of substance use and its diverse correlations with mental health traits

Wormington, B., Thorp, J. G., Gerring, Z. F., Scott, J. G., Akóṣílè, W., & Derks, E. M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116200 · Cited by 10

Addressing India’s alcohol misuse crisis: The urgent need for screening and brief intervention to bridge the healthcare gap

Ghosh, A. (2024) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_785_24 · Cited by 9

“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation

Blum, K., Elman, I., Dennen, C. A., McLaughlin, T., Thanos, P. K., Baron, D. A., Gold, M. S., & Badgaiyan, R. D. (2022) · Annals of Translational Medicine · doi:10.21037/atm-2022-32 · Cited by 9

Developing a Cascade of Care Framework and Surveillance Indicators to Monitor Linkage to and Retention in Care for Substance Use Disorder

Ussery, E. N., Rennick, M., Vivolo-Kantor, A. M., Scott, S., Davidson, A. J., Ishikawa, C., Williams, A. R., & Seth, P. (2024) · Public Health Reports · doi:10.1177/00333549241266994 · Cited by 8

Family-Focused Universal Substance Use Prevention in Primary Care: Advancing a Pragmatic National Healthcare Agenda

Hogue, A., Brykman, K., Guilamo‐Ramos, V., Ilakkuvan, V., Kuklinski, M. R., Matson, P., McKnight, E. R., Powell, T. W., Richter, L., & Walker-Harding, L. R. (2023) · Prevention Science · doi:10.1007/s11121-023-01584-4 · Cited by 8

Examination of the mild, moderate, and severe alcohol use disorder severity indicators using a nationally representative sample.

Bailey, A. J., & McHugh, R. K. (2023) · Psychology of Addictive Behaviors · doi:10.1037/adb0000983 · Cited by 7

Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health

Bailey, A. J., Quinn, P. D., & McHugh, R. K. (2024) · Addiction · doi:10.1111/add.16670 · Cited by 7

Genome-wide association studies of lifetime and frequency of cannabis use in 131,895 individuals

Thorpe, H. H. A., Fontanillas, P., Meredith, J. J., Jennings, M. V., Cupertino, R. B., Pakala, S. R., Elson, S. L., Khokhar, J. Y., Davis, L. K., Johnson, E. C., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03219-2 · Cited by 7

Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods

Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Gelberg, L., Lovejoy, T. I., Bunting, A. M., Cleland, C. M., Lasser, K. E., Beers, D., et al. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00424-8 · Cited by 7

Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid‐Related Loci as the Main Driver of Opioid Use Disorder

Annis, A. C., Gunaseelan, V., Smith, A. V., Abecasis, G. R., Larach, D. B., Zawistowski, M., Frangakis, S. G., & Brummett, C. M. (2024) · Genetic Epidemiology · doi:10.1002/gepi.22588 · Cited by 6

Distinct Chrna5 mutations link excessive alcohol use to types I/II vulnerability profiles and IPN GABAergic neurons

Tochon, L., Henkous, N., Besson, M., Maskos, U., & David, V. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03164-8 · Cited by 6

A social media intervention for high-intensity drinking among emerging adults: a pilot randomized controlled trial

Bonar, E. E., Tan, C. Y., Fernandez, A. C., Goldstick, J. E., Chapman, L., Florimbio, A. R., & Walton, M. A. (2024) · Alcohol and Alcoholism · doi:10.1093/alcalc/agae005 · Cited by 6

Sex Differences in the Development of an Opioid Addiction–Like Phenotype: A Focus on the Telescoping Effect

Towers, E. B., Hsu, K. A., Qillawala, E. I., Fraser, S. D., & Lynch, W. J. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100373 · Cited by 5

Invited Expert Opinion- Bio-informatic and Limitation Di-rectives to Help Adopt Ge-netic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Re-quired Analytic Evidence to Induce Dopamine Homeo-statsis

Blum, K., Gold, M. S., Cadet, J. L., Lewis, M., McLaughlin, T., Braverman, E. R., Elman, I., Carney, B., Cortese, R., Abijo, T., et al. (2023) · Medical Research Archives · doi:10.18103/mra.v11i8.4211 · Cited by 6

Opioid drug seeking after early-life adversity: a role for delta opioid receptors

Levis, S. C., Birnie, M. T., Xie, Y., Kamei, N., Kulkarni, P. V., Montesinos, J. S., Perrone, C. R., Cahill, C. M., Baram, T. Z., & Mahler, S. V. (2024) · Addiction Neuroscience · doi:10.1016/j.addicn.2024.100175 · Cited by 5

Synergistic Epistasis and Systems Biology Approaches to Uncover a Pharmacogenomic Map Linked to Pain, Anti-Inflammatory and Immunomodulating Agents (PAIma) in a Healthy Cohort

Sharafshah, A., Motovali-Bashi, M., Keshavarz, P., & Blum, K. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01504-2 · Cited by 6

Response to the SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

Green, R. P., Blum, K., Lewandrowski, K., Gold, M. S., Lewandrowski, A. P. L., Thanos, P. K., Dennen, C. A., Baron, D. A., Elman, I., Sharafshah, A., et al. (2025) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s514931 · Cited by 5

Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial

Tong, S. T., Ma, K. P. K., Pleho, A., Keiser, B., Hsu, C., Ehde, D. M., Curran, M. C., Tsui, J. I., Raue, P. J., & Stephens, K. A. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00498-y · Cited by 4

Why Are Adolescent Cannabis Use Disorder Treatment Admissions Declining in the US? The Mediated Pathway of State Treatment Admissions Rates before and after Recreational Cannabis Legalization

Mennis, J. L., Stahler, G. J., & Coffman, D. L. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2310500 · Cited by 4

Time to reconsider the best practice models of substance use care for young people

Moensted, M. L., Little, S. C., Haber, P., & Day, C. (2024) · Drug and Alcohol Review · doi:10.1111/dar.13837 · Cited by 4

Prevention and Intervention with Young People as a Critical Public Health Strategy to Curtail the Opioid Epidemic: A Call to Action.

Danielson, C. K., McCauley, J. L., Hinkley, J., Hahn, A. M., Moreland, A. D., López, C. M., Goodyear, M., Adams, Z. W., & McCart, M. (2023) · PubMed · Cited by 4

Treatments for weight gain in schizophrenia

Elman, I. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000992 · Cited by 3

Neurobiology of negative reinforcement as a driving force in alcohol addiction

Vendruscolo, L. F., & Koob, G. F. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.038 · Cited by 4

Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis

Black, J. C., Burkett, H. L., Rockhill, K. M., Olson, R. A., Dart, R. C., & Iwanicki, J. L. (2023) · Journal of Medical Internet Research · doi:10.2196/46747 · Cited by 3

Functional Connectivity Between Basal Forebrain and Superficial Amygdala Negatively Correlates with Social Fearfulness

Zhu, X., Zhou, H., Geng, F., Wang, J., Xu, H., & Hu, Y. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.12.020 · Cited by 3

Value-based decision-making network functional connectivity correlates with substance use and delay discounting behaviour among young adults

Loganathan, K., & Tiego, J. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103424 · Cited by 4

Chronic Pain Management: Recommendations for Curriculum Change

Willenbrock, D., & Lopez, N. (2025) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2025.105375 · Cited by 2

The nosology of addiction as a medical condition: a concise history and review of contemporary perspectives

Garber, M. L., & MacKillop, J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02257-2 · Cited by 3

Lifetime non-fatal overdose experiences among at-risk adolescents and young adults in the emergency department with past-year opioid use in the USA

Seewald, L., Bonar, E. E., Bohnert, A. M., Carter, P. M., King, C. A., Losman, E. D., Bacon, L. J., Wheeler, T., & Walton, M. A. (2024) · Injury Prevention · doi:10.1136/ip-2023-045072 · Cited by 2

Exploring Digital-based Therapies for Adolescents with Substance Use Disorders: A Brief Literature Review

Jo, Y., Edwards, N., Shah, R., & Vas, S. V. (2024) · Journal of Indian Association for Child and Adolescent Mental Health · doi:10.1177/09731342241248896 · Cited by 2

Vulnerable Populations and Substance Use Prevention Service Delivery for the Mental Health Professional

Deeds, B. G., Goldstein, A. B., & Blanco, C. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20240019 · Cited by 2

Should we embrace the term ‘preaddiction’?

Boness, C. L., Kataria, K., & Morris, J. K. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01764-4 · Cited by 2

Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry – Lessons Learned, Past and Present

Blum, K., Sharafshah, A., Khalsa, J. H., Lewandrowski, K., Mohankumar, K., Thanos, P. K., Pinhasov, A., Baron, D. A., Dennen, C. A., Morgan, J. J., et al. (2025) · Journal of Addiction Psychiatry · doi:10.17756/jap.2025-050 · Cited by 2

The Heterogeneous Nature of Substance Use and Substance Use Disorders: Implications for Characterizing Substance-Related Stigma

Sher, K. J. (2023) · Gothic.net · doi:10.1177/15291006231212385 · Cited by 2

Addiction III: From mouse to man

Grigson, P. S., & Hobkirk, A. L. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.12.001 · Cited by 2

Addictive Behavior and Evolutionary Adaptation: Mitigated through Genetic Addiction Risk Severity Early Identification and Awareness Integration Theory

Zeine, F., Jafari, N., Manoukian, E., & Blum, K. (2024) · Medical Research Archives · doi:10.18103/mra.v12i8.5702 · Cited by 1

Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

(2024) · Journal of Addiction Psychiatry · doi:10.17756/jap.2024-045 · Cited by 3

Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity

Shi, Z., Langleben, D. D., Rott, D., Albanese, M. A., & Elman, I. (2024) · Journal of Addictive Diseases · doi:10.1080/10550887.2024.2327739 · Cited by 1

Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site “Subthreshold Opioid Use Disorder Prevention” (STOP) Trial

Abadi, Y. R., Liebschutz, J. M., Subramaniam, G., Stone, R., Appleton, N., Mazel, S. B., Alexander, K., Bose‐Brill, S., Case, A., Gelberg, L., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09613-4 · Cited by 1

A unified theory of restrictive and addictive eating: a life course model integrating generational transmission, neurodevelopmental risk, and ultra-processed food use disorder—a theoretical review

Wiss, D. A., & Logan, A. C. (2026) · Journal of Eating Disorders · doi:10.1186/s40337-026-01618-6 · Cited by 1

Neuroscience-informed psychoeducation for substance use prevention: From neurodevelopmental risk to resilient decision-making

Vassileva, J., Rezapour, T., Psederska, E., Ekhtiari, H., & Squeglia, L. M. (2026) · Progress in brain research · doi:10.1016/bs.pbr.2026.09.002 · Cited by 1

Making alcohol and tobacco preventable deaths truly preventable! Addiction as a modifiable risk factor for alcohol and tobacco preventable mortality

Baillet, E., Serre, F., & Auriacombe, M. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01399-x · Cited by 1

Patient Attitudes Toward Substance Use Screening and Discussion in Primary Care: Comparison Across Demographic Characteristics

Frost, M. C., McNeely, J., Appleton, N., Farkas, S., Wakeman, S. E., Wilens, T. E., Kannry, J. L., McLeman, B. M., Nesin, N., Rosenthal, R. N., et al. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251364034 · Cited by 1

Neurobiological subtypes in alcohol use disorder and their phenotypic and clinical profiles

Brucar, L. R., Rawls, E., & Zilverstand, A. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03748-4 · Cited by 1

Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?

Blum, K., Bowirrat, A., Braverman, E. R., Dennen, C. A., Zeine, F., Jafari, N., Sunder, K. R., Thanos, P. K., Baron, D. A., Barh, D., et al. (2023) · PubMed · Cited by 1

Substance use disorder risk assessment: positive emotional experiences with first time use and substance use disorder risk

Arscott, K. E., Eget, D. M., Marcos, M. C., & Piper, B. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1368598 · Cited by 1

Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative review

Hanna, C., Comstock, F., Chatrath, S., Posner, A. R., Butsch, J. L., Blum, K., Gold, M. S., Georger, L. A., Mastrandrea, L. D., Quattrin, T., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1516122 · Cited by 1

Association of dopamine D2-like and D3 receptor function with initial sensitivity to cocaine reinforcement in male rhesus monkeys

Czoty, P. W., Tryhus, A. M., Sai, K. K. S., Nader, S. H., & Epperly, P. M. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148323 · Cited by 1

Editorial: Reviews in opioid use disorders

Walwyn, W. M., & Evoy, K. E. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1467826 · Cited by 1

Substance Use Disorder Risk Assessment: Preventing Use DisorderPreprint

Arscott, K. E., Eget, D. M., Marcos, M. C., & Piper, B. J. (2022) · medRxiv · doi:10.1101/2022.12.08.22283157

Pattern and Prevalence of Drug Use among a Population of Mentally Ill Patients attending the University of Port Harcourt Teaching Hospital

Nkporbu, A. K., & Ojule, I. N. (2023) · Addiction Research · doi:10.33425/2639-8451.1034

Futuristic Exploration of Addiction Neuroscience in the Genomic Era

Blum, K., Elman, I., Bowirrat, A., Baron, D. A., Thanos, P. K., Hanna, C., Badgaiyan, R. D., & Gold, M. S. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s439837

Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD)

Herrera, M., Johnson, J., Lim, S., Morales, K., Wilson, J. D., Hadland, S. E., Metzger, D. S., Wood, S., & Dowshen, N. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111132

Genetic addiction risk analysis for “preaddiction” severity index (PAI): A neurobiological behavioral octopus

Blum, K., Han, D. C., Bowirrat, A., Downs, B. W., Bagchi, D., Thanos, P. K., Baron, D. A., Braverman, E. R., Dennen, C. A., Giordano, J., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00028-0

Revisiting Preaddiction

Miller, S. C., Levy, S., Saxon, A. J., Tetrault, J. M., Rosenthal, R. N., Wakeman, S. E., & Vocci, F. J. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001357

Genes and Genetic Testing in Addiction Medicine

Blum, K., Madigan, M. A., Fuehrlein, B., Thanos, P. K., Lewandrowski, K., Sharafshah, A., Elman, I., Baron, D. A., Bowirrat, A., Pinhasov, A., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00227-x

Early access to post-emergency addiction care: ASAP project

Demina, A., Meille, V., Petit, B., Cannard, J.-F., & Trojak, B. (2024) · L Encéphale · doi:10.1016/j.encep.2024.07.004

Large-scale longitudinal analysis of the progression of alcohol use among members of a social media platform: an observational study

Andrade, F. C., Meyerson, W. U., & Hoyle, R. H. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2414324

Substance Use Disorders

Stead, V. E., Lumb, A. B., Brasch, J. S., & MacKillop, J. M. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009086264.013

Prescription Opioid Medication Survey: A Tool to Collect Deep Phenotypic Data on the Multifactorial Pathways to Opioid Use Disorder in Clinical and Population-Based Cohorts

Courchesne‐Krak, N. S., Chandrasekaran, A. R., Gonzalez, J., Bianchi, S. B., Tran, V., Johnson, E. O., Troiani, V., Hettema, J. M., Stein, M. B., Coon, H. H., et al. (2025) · Complex Psychiatry · doi:10.1159/000546389

Quantitative Economon Model of Transactions for Drugs and Other CommoditiesPreprint

Haynes, J. M., da Rosa, J. C., Butelman, E. R., Hursh, S. R., & Negus, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.08.663082

The Gendered Well-being Assessment: addressing trauma, complex needs & social determinants of health

Ruprai, D., Pemberton, S. A., & Summers, R. (2025) · International Journal for Equity in Health · doi:10.1186/s12939-025-02553-9

Dopaminergic Homeostatic Therapy (DHT™) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS®) Screening.

Lewandrowski, K.-U., Bowirrat, A., Pinhasov, A., Sharafshah, A., Gold, M. S., Fuehrlein, B., Elman, I., Dennen, C. A., Thanos, P. K., Hanna, C., et al. (2025) · PubMed

Addiction and preaddiction.

Lh, N. (1971) · PubMed · Cited by 3

Medikalisierung von Risikoverhaltensweisen oder Missing link zwischen Frühintervention und Versorgung? Zum Konzept der „Pre-Addiction“

Bischof, G. (2023) · Infinite Science GmbH · doi:10.18416/dsk.2023.882

Should we embrace the term ‘preaddiction’?

Boness, C. L., Kataria, K., & Morris, J. K. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01764-4 · Cited by 2

Preparing to treat addictions and co-occurring psychiatric disorders.

Muchowski, P. M., Lemieux, P. R., & Hillis, S. B. (2009) · PubMed

Revisiting Preaddiction

Miller, S. C., Levy, S., Saxon, A. J., Tetrault, J. M., Rosenthal, R. N., Wakeman, S. E., & Vocci, F. J. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001357